VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_13-vv-00797
Package ID: USCOURTS-cofc-1_13-vv-00797
Petitioner: Luis Gamardo
Filed: 2013-10-15
Decided: 2015-12-17
Vaccine: MMR
Vaccination date: 2010-11-15
Condition: immune (or “idiopathic”) thrombocytopenic purpura (“ITP”)
Outcome: compensated
Award amount USD: 50000

AI-assisted case summary:
On October 15, 2013, Luis Gamardo filed a petition under the National Vaccine Injury Compensation Program, alleging that a Measles, Mumps, and Rubella (MMR) vaccine administered on November 15, 2010, caused him to develop immune thrombocytopenic purpura (ITP). The respondent, the Secretary of Health and Human Services, denied that the MMR vaccine caused petitioner's ITP or any other injury, and further denied that his current disabilities were a sequela of a vaccine-related injury. On May 1, 2015, both parties filed a joint stipulation to settle the case. Special Master Lisa Hamilton-Fieldman reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court. As per the stipulation, Petitioner Luis Gamardo was awarded a lump sum of $50,000.00, payable to him, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The public decision does not describe the specific onset of symptoms, clinical details, diagnostic tests, treatments, or expert witnesses involved in this case. Ronald Homer of Conway, Homer & Chin-Caplan, P.C. represented the Petitioner, and Glenn MacLeod of the United States Department of Justice represented the Respondent.

Theory of causation field:
Petitioner Luis Gamardo alleged that the MMR vaccine administered on November 15, 2010, caused him to develop immune (or idiopathic) thrombocytopenic purpura (ITP). The Respondent denied causation. The parties reached a joint stipulation on May 1, 2015, agreeing to a settlement. Special Master Hamilton-Fieldman approved the stipulation, adopting it as the Court's decision. Petitioner was awarded $50,000.00 as compensation for all damages under 42 U.S.C. § 300aa-15(a). The public decision does not detail the specific medical mechanism, expert testimony, or evidence presented regarding causation, relying instead on the parties' stipulation. Attorneys involved were Ronald Homer for Petitioner and Glenn MacLeod for Respondent.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_13-vv-00797-0
Date issued/filed: 2015-05-22
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 5/1/2015) regarding 26 DECISION Stipulation/Proffer. Signed by Special Master Lisa Hamilton-Fieldman. (mb) Copy to parties.
--------------------------------------------------------------------------------
Case 1:13-vv-00797-UNJ Document 27 Filed 05/22/15 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 13-797V
Filed: May 1, 2015
* * * * * * * * * * * * * * * * UNPUBLISHED
LUIS GAMARDO, *
* Special Master Hamilton-Fieldman
Petitioner, *
* Joint Stipulation on Damages;
v. * Measles Mumps Rubella (“MMR”)
* Vaccine; Idiopathic
SECRETARY OF HEALTH * Thrombocytopenic Purpura (“ITP”).
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * * * * *
Ronald Homer, Conway, Homer & Chin-Caplan, P.C., Boston, MA, for Petitioner.
Glenn MacLeod, United States Department of Justice, Washington, D.C., for Respondent.
DECISION1
On October 15, 2013, Luis Gamardo (“Petitioner”) filed a petition pursuant to the
National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-1 to -34 (2006).
Petitioner alleged that the administration of a Measles, Mumps, and Rubella (“MMR”) vaccine
on November 15, 2010 caused him to suffer from immune (or “idiopathic”) thrombocytopenic
purpura (“ITP”).
On May 1, 2015, the parties filed a stipulation in which they state that a decision should
1 Because this decision contains a reasoned explanation for the undersigned’s action in this case,
the undersigned intends to post this ruling on the website of the United States Court of Federal
Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116
Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by
Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any
information furnished by that party: (1) that is a trade secret or commercial or financial in
substance and is privileged or confidential; or (2) that includes medical files or similar files, the
disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule
18(b).
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
42 U.S.C. §§ 300aa-1 to -34 (2006) (Vaccine Act or the Act). All citations in this decision to
individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
1

Case 1:13-vv-00797-UNJ Document 27 Filed 05/22/15 Page 2 of 7
be entered awarding compensation. Respondent denies that the MMR vaccine caused
Petitioner’s ITP injury or any other injury and further denies that his current disabilities are a
sequela of a vaccine-related injury. Nevertheless, the parties agree to the joint stipulation,
attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as
the decision of the Court in awarding damages, on the terms set forth therein.
The parties stipulate that Petitioner shall receive the following compensation:
A lump sum of $50,000.00, in the form of a check payable to Petitioner, representing
compensation for all damages that would be available under 42 U.S.C. § 300aa-
15(a).
Stipulation ¶ 8.
The undersigned approves the requested amount for Petitioner’s compensation.
Accordingly, an award should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’
stipulation.3
IT IS SO ORDERED.
s/ Lisa Hamilton-Fieldman
Lisa Hamilton-Fieldman
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
notice renouncing the right to seek review.
2

CCaassee 11::1133--vvvv--0000779977--UUNNJJ DDooccuummeenntt 2257 FFiilleedd 0055//0212//1155 PPaaggee 13 ooff 57

CCaassee 11::1133--vvvv--0000779977--UUNNJJ DDooccuummeenntt 2257 FFiilleedd 0055//0212//1155 PPaaggee 24 ooff 57

CCaassee 11::1133--vvvv--0000779977--UUNNJJ DDooccuummeenntt 2257 FFiilleedd 0055//0212//1155 PPaaggee 35 ooff 57

CCaassee 11::1133--vvvv--0000779977--UUNNJJ DDooccuummeenntt 2257 FFiilleedd 0055//0212//1155 PPaaggee 46 ooff 57

CCaassee 11::1133--vvvv--0000779977--UUNNJJ DDooccuummeenntt 2257 FFiilleedd 0055//0212//1155 PPaaggee 57 ooff 57